ArticleArthritis & rheumatology (Hoboken, N.J.)2015
Half-life and safety of canakinumab in pediatric patients: comment on the article by Ilowite et Al.
Hermine Brunner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it